Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

47.07
Delayed Data
As of Jul 21
 -0.72 / -1.51%
Today’s Change
37.35
Today|||52-Week Range
55.38
+21.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization324.0K408.0K492.0K489.0K
 
 
 
 
 
 
Operating ExpensesGross Income-324.0K-408.0K-492.0K-489.0K
 
 
 
 
 
General Expenses41.5M38.0M45.8M79.4M
 
 
 
 
 
Research And Development26.9M20.9M22.6M51.9M
 
 
 
 
 
Total Operating Expenses41.8M38.4M46.3M79.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-41.8M-38.4M-46.3M-79.9M
 
 
 
 
 
Other Expenses868.0K844.0K863.0K879.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-40.3M-36.9M-44.7M-78.3M
 
 
 
 
 
Net Income-40.3M-36.9M-44.7M-78.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS86.7M86.8M86.9M87.3M
 
 
 
 
 
Shares To Calculate EPS Diluted86.7M86.8M86.9M87.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.46-$0.43-$0.51-$0.90
 
 
 
 
 
EPS Diluted-$0.46-$0.43-$0.51-$0.90